-
Mashup Score: 37CDC’s ACIP Decides Not to Vote on Recommendations for Johnson & Johnson COVID-19 Vaccine - 3 year(s) ago
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) met today to discuss the blood clots’ issue and offered guidance on heparin usage in these cases.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 4What Is The Link Between COVID-19 Vaccines and Thrombosis Risk? - 3 year(s) ago
A thrombosis expert details cerebral venous thrombosis, the side effect reported in a half-dozen women administered the Johnson & Johnson vaccine.
Source: HCPLiveCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 6Putting the J&J Vaccine "Pause" Into Perspective - 3 year(s) ago
WebMD’s Chief Medical Officer, John Whyte, MD, MPH, helps put the recommended Johnson & Johnson COVID-19 vaccine “pause” into perspective.
Source: WebMDCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5What Does the Johnson & Johnson COVID-19 Vaccine Pause Mean? - 3 year(s) ago
Carlos del Rio, MD, discusses the United States’ pandemic situation in assessing the blood clot events observed in 6 Johnson & Johnson vaccine recipients.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 4HAN Archive - 00442 | Health Alert Network (HAN) - 3 year(s) ago
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC).
Source: emergency.cdc.govCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1
The FDA and U.S. Centers for Disease Control and Prevention (CDC) are recommending that U.S. states pause their administration of Johnson & Johnson’s Janssen COVID-19 Vaccine Candidate while they review six reported cases of patients developing what they termed rare and severe blood clots after receiving the vaccine.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1
Jason Gallagher, PharmD, adds context behind the FDA and CDC’s decision to pause and review blood clotting events in 6 women given the company’s COVID-19 vaccine.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1
Administration of the Johnson & Johnson COVID-19 vaccine has been paused following a few instances of blood clots within weeks of vaccination.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
The FDA and U.S. Centers for Disease Control and Prevention (CDC) are recommending that U.S. states pause their administration of Johnson & Johnson’s Janssen COVID-19 Vaccine Candidate while they review six reported cases of patients developing what they termed rare and severe blood clots after receiving the vaccine.
Categories: Future of Medicine, Latest HeadlinesTweet
#BREAKING #CDC ACIP decides not to vote on recommendations for #JohnsonandJohnson #COVID19 #vaccine opting to wait for more data https://t.co/N2WQ6G94Uh